Cargando…
Targeting the Divergent Roles of STK3 Inhibits Breast Cancer Cell Growth and Opposes Doxorubicin-Induced Cardiotoxicity In Vitro
SIMPLE SUMMARY: Breast cancer is the second leading cause of cancer-related death in women. The increase in effective therapies and breast cancer survivorship has highlighted the cardiotoxic effects of many chemotherapies. In this study, we investigated Serine-Threonine Kinase 3 (STK3), a kinase in...
Autores principales: | Nam, Jiung, Schirmer, Amelia U., Loh, Chelsea, Drewry, David H., Macias, Everardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216518/ https://www.ncbi.nlm.nih.gov/pubmed/37345153 http://dx.doi.org/10.3390/cancers15102817 |
Ejemplares similares
-
Isorhamnetin Protects against Doxorubicin-Induced Cardiotoxicity In Vivo and In Vitro
por: Sun, Jing, et al.
Publicado: (2013) -
INKing the Cardiotoxicity Out of Doxorubicin
por: Guo, Zhen, et al.
Publicado: (2023) -
Activation of the MET receptor attenuates doxorubicin‐induced cardiotoxicity in vivo and in vitro
por: Gallo, Simona, et al.
Publicado: (2020) -
Role of acetylation in doxorubicin-induced cardiotoxicity
por: Li, Daisong, et al.
Publicado: (2021) -
Dipyridamole ameliorates doxorubicin-induced cardiotoxicity
por: Alyasiry, Esraa, et al.
Publicado: (2022)